ACXP News and Press, Acurx Pharmaceuticals Inc. From 12/06/21

Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI) - First patient enrolled in Phase 2b comparative trial segment vs vancomycin, current standard of care - Previously completed Ph...

Acurx Pharmaceuticals, Inc. (ACXP) Q3 2021 Earnings Conference Call Nov 15, 2021 08:30 AM ET Company Participants David Luci - President and CEO Robert Shawah - Co-Founder and CFO Conference Call Participants Jason McCarthy - Maxim Group Presentation Operator [Technical Difficulty] David Luci...

Acurx Pharmaceuticals (NASDAQ:ACXP): Q3 GAAP EPS of -$0.46. Cash of $14.5M Press Release For further details see: Acurx Pharmaceuticals reports Q3 results

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , Nov. 12, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stag...

Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference PR Newswire STATEN ISLAND, N.Y. , Nov. 1, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acur...

Acurx Pharmaceuticals to Discuss 2021 Third Quarter Financial Results on November 15, 2021 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , Oct. 27, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the ...

Gainers: Xenon Pharmaceuticals XENE +76%, Milestone Scientific (NYSE:MLSS) +15%, Clene (NASDAQ:CLNN) +12%, OpGen OPGN +11%, Adverum Biotechnologies ADVM +8%. Losers: Owlet (NYSE:OWLT) -25, REGENXBIO (NASDAQ:RGNX) -21%, Omeros (NASDAQ...

Acurx Presents Positive Ibezapolstat Microbiome Data from Its Phase 2a Trial at IDWeek - Patient fecal samples were evaluated for C. difficile culture and microbiome changes - Ph2a trial demonstrated 100% clinical cure and sustained clinical cure - Favorable microbiome c...

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021 PR Newswire WASHINGTON , Sept. 30, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and s...

Acurx Pharmaceuticals to Participate in the A.G.P. Biotech and Specialty Pharma Conference October 13, 2021 PR Newswire STATEN ISLAND, N.Y. , Sept. 29, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical sta...